Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is poised for growth with their innovative technological solutions and ambitious expansion plans, demonstrated through their new product offerings and targets. The company's strong focus on improving member experience and utilizing AI technology is expected to drive revenue, but potential price pressure and share lockups pose potential challenges for their stock in the future.

Bears say

Hinge Health is facing significant risks, including the potential inability to attract and retain clients, failure to meet performance guarantees, and a reliance on a limited number of health plans and partners. While they have achieved strong client satisfaction and retention rates currently, their financial model is heavily reliant on member enrollment and engagement, placing pressure on the company to continuously market and engage members. Additional risks include the need for brand permission to expand into new areas, with management acknowledging that oncology may not be a feasible extension from their core MSK offering.

HNGE has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 15 analysts, HNGE has a Buy consensus rating as of Aug 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.